![Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41573-020-0073-9/MediaObjects/41573_2020_73_Fig5_HTML.png)
Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery
211At-Labeled Polymer Nanoparticles for Targeted Radionuclide Therapy of Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR)-Overexpressed Cancer | Bioconjugate Chemistry
![Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41573-020-0073-9/MediaObjects/41573_2020_73_Fig3_HTML.png)
Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery
![Current outlook on radionuclide delivery systems: from design consideration to translation into clinics | Journal of Nanobiotechnology | Full Text Current outlook on radionuclide delivery systems: from design consideration to translation into clinics | Journal of Nanobiotechnology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12951-019-0524-9/MediaObjects/12951_2019_524_Fig1_HTML.png)
Current outlook on radionuclide delivery systems: from design consideration to translation into clinics | Journal of Nanobiotechnology | Full Text
![Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41573-020-0073-9/MediaObjects/41573_2020_73_Fig1_HTML.png)
Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery
![Pharmaceutics | Free Full-Text | The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research Pharmaceutics | Free Full-Text | The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research](https://www.mdpi.com/pharmaceutics/pharmaceutics-11-00560/article_deploy/html/images/pharmaceutics-11-00560-g001.png)
Pharmaceutics | Free Full-Text | The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research
![Prospects in the development of natural radioprotective therapeutics with anti-cancer properties from the plants of Uttarakhand region of India - ScienceDirect Prospects in the development of natural radioprotective therapeutics with anti-cancer properties from the plants of Uttarakhand region of India - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0975947616300122-gr2.jpg)
Prospects in the development of natural radioprotective therapeutics with anti-cancer properties from the plants of Uttarakhand region of India - ScienceDirect
![Radioprotective agents to prevent cellular damage due to ionizing radiation | Journal of Translational Medicine | Full Text Radioprotective agents to prevent cellular damage due to ionizing radiation | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-017-1338-x/MediaObjects/12967_2017_1338_Fig1_HTML.gif)
Radioprotective agents to prevent cellular damage due to ionizing radiation | Journal of Translational Medicine | Full Text
![Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41573-020-0073-9/MediaObjects/41573_2020_73_Fig4_HTML.png)